Name of this trial: Artemide-HCC01 What type of cancer is this for? Advanced Hepatocellular Cancer Who is this trial for? Patients who have advanced kidney cancer that have not had prior treatment in advanced setting. What biomarkers are involved? Central PD-L1 testing, however positivity not dependent on inclusivity What is the National Clinical Trial #?
Phone: (800) 411-7999
